Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells - PubMed (original) (raw)
Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells
Paul K Wright et al. Int J Clin Exp Pathol. 2009.
Abstract
Estrogens are critical mediators of breast tumorigenesis. This occurs via the action of estrogens on the estrogen receptor (ER), which regulates the transcriptome of breast cancer cells. Despite the long history of the search for estrogen-regulated genes in breast cancer, knowledge of the E2-regulated transcriptome and its effects is incomplete. We used Affymetrix GeneChips to profile the effects of estradiol on the expression of genes in EFF-3, EFM-19 and MCF-7 cells. In addition to many well-characterized estrogen-regulated genes, this identified a novel group of genes that have roles in vesicle trafficking, including exocytosis. Recent evidence in the literature supports a role for vesicle trafficking in tumorigenesis. We focused on five genes (SYTL5, RAB27B, SNX24, GALNT4 and SLC12A2/NKCC1/BSC2) and confirmed their estrogen-regulation using quantitative real-time PCR (qPCR). qPCR also demonstrated that these five genes were expressed in invasive breast carcinoma tissue. Immunohistochemistry showed expression of SYTL5 in cells of normal breast ductal epithelium, ductal carcinoma in-situ (DCIS) and invasive breast carcinoma. The results suggest that a significant effect of estrogens is to regulate the expression of genes that affect diverse aspects of vesicle trafficking including exocytosis.
Keywords: Breast cancer; RAB GTPase; estrogen; exocytosis; synaptotagmin-like protein; vesicle.
Figures
Figure 1
qPCR demonstrating the mRNA expression of TFF1 in EFF-3, EFM-19, MCF-7, MDA-MB-231, Hs578T and SK-BR-3 cells after 48 hours E2-stimulation (E2) compared with steroid withdrawn (CONT) samples. (Error bars are standard deviation of three independent replicates.)
Figure 2
qPCR demonstrating E2-regulation of SYTL5, GALNT4, SNX24, RAB27B and SLC12A2. A. E2-regulation of all 5 genes in EFF-3, EFM-19 and MCF-7 cells showing mRNA fold change after 48 hours E2-treatment. B. The effects of E2-stimulation for 48 hours on SYTL5 mRNA expression on 6 breast cancer cell lines comparing steroid withdrawn (CONT) with E2-stimulated (E2) samples. C. SYTL5 mRNA expression in MCF-7 cells after E2-stimulation for 0 to 96 hours, comparing steroid withdrawn (CONT) with E2-stimulated (E2) samples. D. SYTL5 mRNA expression in MCF-7 cells after 48 hours in the presence of 0 – 10−7M E2. (Error bars are standard deviation of three independent replicates.)
Figure 3
mRNA expression of SYTL5, GALNT4, SNX24, RAB27B and SLC12A2 in invasive breast carcinoma tissue samples and MCF-7 cells. (• ERα+ tumors, ○ ERα- tumors, – mean mRNA expression, X MCF-7 cells. Y-axis: mRNA expression in relative units.)
Figure 4
SYTL5 protein expression in breast cancer. A. SYTL5 protein expression determined by Western blotting in MCF-7 and Hs578T cells. B–F. Immunohistochemistry showing SYTL5 protein expression in normal breast tissue (strong staining) (B), DCIS (strong staining) (C), ER- invasive breast carcinoma NST (moderate staining) (D) and ER+ invasive breast carcinoma NST (strong staining) (E and F). (Scale bar = 100μm)
Similar articles
- 17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.
Wright PK, Jones SB, Ardern N, Ward R, Clarke RB, Sotgia F, Lisanti MP, Landberg G, Lamb R. Wright PK, et al. Oncotarget. 2014 May 30;5(10):3055-65. doi: 10.18632/oncotarget.1824. Oncotarget. 2014. PMID: 24931391 Free PMC article. - Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.
Hendrix A, Maynard D, Pauwels P, Braems G, Denys H, Van den Broecke R, Lambert J, Van Belle S, Cocquyt V, Gespach C, Bracke M, Seabra MC, Gahl WA, De Wever O, Westbroek W. Hendrix A, et al. J Natl Cancer Inst. 2010 Jun 16;102(12):866-80. doi: 10.1093/jnci/djq153. Epub 2010 May 18. J Natl Cancer Inst. 2010. PMID: 20484105 Free PMC article. - Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC. Zou Y, et al. Breast Cancer Res. 2008;10(1):R21. doi: 10.1186/bcr1872. Epub 2008 Feb 29. Breast Cancer Res. 2008. PMID: 18312651 Free PMC article. - New development in intracrinology of breast carcinoma.
Sasano H, Suzuki T, Nakata T, Moriya T. Sasano H, et al. Breast Cancer. 2006;13(2):129-36. doi: 10.2325/jbcs.13.129. Breast Cancer. 2006. PMID: 16755106 Review. - Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
Miki Y, Suzuki T, Sasano H. Miki Y, et al. J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):68-71. doi: 10.1016/j.jsbmb.2008.12.021. J Steroid Biochem Mol Biol. 2009. PMID: 19444935 Review.
Cited by
- Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study.
Zheng G, Chattopadhyay S, Sundquist J, Sundquist K, Ji J. Zheng G, et al. Eur J Epidemiol. 2024 May;39(5):535-548. doi: 10.1007/s10654-024-01103-x. Epub 2024 Feb 24. Eur J Epidemiol. 2024. PMID: 38396187 Free PMC article. - Unraveling the Intricate Link: Deciphering the Role of the Golgi Apparatus in Breast Cancer Progression.
Dumitru AV, Stoica EE, Covache-Busuioc RA, Bratu BG, Cirstoiu MM. Dumitru AV, et al. Int J Mol Sci. 2023 Sep 14;24(18):14073. doi: 10.3390/ijms241814073. Int J Mol Sci. 2023. PMID: 37762375 Free PMC article. Review. - Goat SNX29: mRNA expression, InDel and CNV detection, and their associations with litter size.
Wang Q, Bi Y, Wang Z, Zhu H, Liu M, Wu X, Pan C. Wang Q, et al. Front Vet Sci. 2022 Aug 10;9:981315. doi: 10.3389/fvets.2022.981315. eCollection 2022. Front Vet Sci. 2022. PMID: 36032302 Free PMC article. - Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors.
Smart E, Semina SE, Alejo LH, Kansara NS, Frasor J. Smart E, et al. Cancers (Basel). 2022 Jun 9;14(12):2848. doi: 10.3390/cancers14122848. Cancers (Basel). 2022. PMID: 35740514 Free PMC article. - Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer.
Vafeiadou V, Hany D, Picard D. Vafeiadou V, et al. Cancers (Basel). 2022 Feb 14;14(4):954. doi: 10.3390/cancers14040954. Cancers (Basel). 2022. PMID: 35205702 Free PMC article.
References
- Nilsson S, Makela S, Treuter E, Tujaque M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev. 2001;81:1535–1565. - PubMed
- Ackermann GE, Carr BR. Estrogens. Rev Endocr Metab Disord. 2002;3:225–230. - PubMed
- Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005;23:1616–1622. - PubMed
- Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer. 2003;10:179–186. - PubMed
- Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y, Meltzer PS. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res. 2003;63:7158–7166. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources